About this trial
The objective of this clinical trial is to evaluate the safety and efficacy of Versius in Inguinal Hernia repair surgery
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients 22 years of age and older, deemed eligible for elective minimal invasive inguinal Hernia repair surgery.
Patients providing written informed consent to participate in the study.
Disqualifiers
Patient unwilling to provide informed consent.
Medical contraindication for general anaesthesia or minimally invasive procedure.
Patient participation in an interventional clinical study that could impact primary outcomes results.
Patient who falls into American Society of Anaesthesiologists (ASA) Class IV or above.
Trial design
Single group
Treatments tested in this trial
Versius Surgical System
DeviceModular robotic system intended to assist in the accurate control of its surgical endoscopic instruments across a range of surgical procedures.
Treatment groups
Trial outcomes
Primary outcomes
Success rate
Rate of successful completion of robotic assisted surgery as planned without unplanned conversion to other laparoscopic or open surgery
Serious Adverse Event rate
Rate of total procedure related serious adverse events
Secondary outcomes
Operative time
Surgical time from skin incision to skin closure
Estimated blood loss
Amount of blood estimated to be lost during surgery (in mL)
Intra-operative adverse events
Adverse events that occur during surgery
Blood transfusion
Need for blood transfusion during surgery as well as amount transfused
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
CMR Surgical Ltd
Lead sponsor
Hospital Universitari de Bellvitge
Collaborator
Niguarda Hospital
Collaborator